Invectys
Cancer treatment research
Invectys has raised €19M across 2 funding rounds, most recently a Series A round in Oct 2018. Based in Paris, France; active in Healthtech. Data as of 4 Nov 2026.
Paris, Francewww.invectys.com ↗
Total raised
€19M
€19,000,000
Funding rounds
2
Investors
0
distinct backers
Active since
2017-07
latest 2018-10
Funding by year
EUR raised per yearInvectys — funding by year — interactive chart.
Data table
| Invectys — funding by year | |
|---|---|
| 2017 | €4.0M |
| 2018 | €15M |
Signals
Medium confidenceRaise-next likelihood10
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-10-01 | Series A | €15M | — | View deal → |
| 2017-07-16 | Other | €4.0M | — | View deal → |
Related news
Similar companies
same sector, similar size- Alderaan Biotechnology€19MFrance · Healthtech
- CardioLogs€18MFrance · Healthtech
- NH TherAguix€13MFrance · Healthtech
- Cardiology Ai€14MFrance · Healthtech
- SeqOne Genomics€20MFrance · Healthtech
- Core Biogenesis€20MFrance · Healthtech
Global coverage: FundingData